• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

澳大利亚的药物与治疗委员会:预期表现与实际表现

Drug and Therapeutics Committees in Australia: expected and actual performance.

作者信息

Weekes L M, Brooks C

机构信息

New South Wales Therapeutic Assessment Group Inc, Sydney, Australia.

出版信息

Br J Clin Pharmacol. 1996 Nov;42(5):551-7. doi: 10.1111/j.1365-2125.1996.tb00048.x.

DOI:10.1111/j.1365-2125.1996.tb00048.x
PMID:8951185
Abstract
  1. This study describes stakeholders' opinions on Drug and Therapeutics Committees (DTCs) and measures the composition, activities and perceived effectiveness of DTCs in Australia. 2. Focus groups explored the opinions of clinicians, consumers and administrators on the goals, objectives and strategies of DTCs. 3. A national survey was sent to 306 hospitals to collect data on the composition, committee processes, goals, objectives, educational activities, policies and decision making of DTCs. 4. Stakeholders believed the DTC should optimise therapeutic health outcomes for patients and economic outcomes for the hospital. Important objectives were availability of safe, efficacious and cost-effective medicines, affordability of medicines and quality use of medicines. 5. The national survey of DTCs found that over 92% of respondents had a DTC in their hospital. Composition was generally representational and most commonly included members from the disciplines of internal medicine, pharmacy and nursing. More than half the DTCs had executive authority although only 21% had an appeals mechanism. 6. The most commonly cited issues for DTCs in 1994-95 were quality drug use, drug policies and spending on high cost drugs. 7. While access to clinical pharmacologists and specialist drug utilisation evaluation (DUE) pharmacists was poor, 71% of DTCs had access to DUE data of some sort. Guidelines (61%), prescribing restrictions (60%) and pharmacist monitoring (63%) were the most commonly used strategies to implement DTC policies and decisions. Audit-feedback activities (61%) and drug bulletins (56%) were the most commonly used interventions. 8. Available information for formulary decision making varied with small rural hospitals having access to significantly less information. The most commonly used information was availability of a therapeutic alternative (87%), efficacy (83%), cost (80%) and estimated usage (78%). 9. On average DTCs reported an ability to implement 75% of decisions (range 0-95%) with teaching hospitals perceived to perform better than other hospital types. 10. This study reveals a high level of expectation for DTC activities and achievements. In Australia DTCs were involved in policy, education and management initiatives to promote best practice in therapeutics. Few committees appeared to have adequate resources to extend services to their wider community.
摘要
  1. 本研究描述了利益相关者对药物与治疗委员会(DTCs)的看法,并衡量了澳大利亚DTCs的组成、活动及感知到的有效性。2. 焦点小组探讨了临床医生、消费者和管理人员对DTCs的目标、目的和策略的看法。3. 向306家医院发送了一项全国性调查,以收集有关DTCs的组成、委员会流程、目标、目的、教育活动、政策和决策的数据。4. 利益相关者认为,DTC应该为患者优化治疗健康结果,并为医院优化经济结果。重要目标包括提供安全、有效且具有成本效益的药物、药物的可负担性以及药物的合理使用。5. 对DTCs的全国性调查发现,超过92%的受访者所在医院设有DTC。其组成通常具有代表性,最常见的成员包括内科、药学和护理领域的人员。超过一半的DTC拥有执行权,尽管只有21%设有上诉机制。6. 1994 - 1995年DTCs最常被提及的问题是药物的合理使用、药物政策以及高成本药物的支出。7. 虽然临床药理学家和专科药物利用评估(DUE)药师的可及性较差,但71%的DTC能够获取某种形式的DUE数据。指南(61%)、处方限制(60%)和药师监测(63%)是实施DTC政策和决策最常用的策略。审核反馈活动(61%)和药物通报(56%)是最常用的干预措施。8. 用于处方集决策的可用信息各不相同,小型农村医院获取的信息明显较少。最常用的信息是是否有治疗替代方案(87%)、疗效(83%)、成本(80%)和估计用量(78%)。9. 平均而言,DTCs报告称能够执行75%的决策(范围为0 - 95%),教学医院被认为比其他类型的医院表现更好。10. 本研究揭示了对DTC活动和成果的高度期望。在澳大利亚,DTC参与了政策、教育和管理举措,以促进治疗方面的最佳实践。似乎很少有委员会拥有足够的资源将服务扩展到更广泛的社区。

相似文献

1
Drug and Therapeutics Committees in Australia: expected and actual performance.澳大利亚的药物与治疗委员会:预期表现与实际表现
Br J Clin Pharmacol. 1996 Nov;42(5):551-7. doi: 10.1111/j.1365-2125.1996.tb00048.x.
2
Perspectives on Drug and Therapeutics Committee policy implementation.药物与治疗学委员会政策实施的观点。
Res Social Adm Pharm. 2005 Dec;1(4):526-45. doi: 10.1016/j.sapharm.2005.09.001.
3
"There are ways … drug companies will get into DTC decisions": How Australian drug and therapeutics committees address pharmaceutical industry influence.“有一些方法……制药公司将参与直接面向消费者的决策”:澳大利亚药品和治疗学委员会如何应对制药行业的影响。
Br J Clin Pharmacol. 2021 May;87(5):2341-2353. doi: 10.1111/bcp.14636. Epub 2020 Nov 26.
4
Drug and therapeutics committees in Nigeria: evaluation of scope and functionality.尼日利亚的药物和治疗学委员会:评估范围和功能。
Expert Rev Clin Pharmacol. 2018 Dec;11(12):1255-1262. doi: 10.1080/17512433.2018.1549488. Epub 2018 Nov 30.
5
Drug and therapeutics committees: the relationships among structure, function, and effectiveness.药物与治疗学委员会:结构、功能与有效性之间的关系
Hosp Pharm. 1993 Jun;28(6):492-3, 496-8, 508.
6
Prioritising drug and therapeutics committee (DTC) decisions: a national survey.药物与治疗学委员会(DTC)决策的优先级排序:一项全国性调查。
Pharm World Sci. 2007 Apr;29(2):90-6. doi: 10.1007/s11096-006-9074-y. Epub 2006 Dec 23.
7
Drug and therapeutics committees in Jordanian hospitals: a nation-wide survey of organization, activities, and drug selection procedures.约旦医院的药物与治疗学委员会:一项关于组织、活动及药物选择程序的全国性调查。
Pharm Pract (Granada). 2019 Oct-Dec;17(4):1590. doi: 10.18549/PharmPract.2019.4.1590. Epub 2019 Nov 3.
8
The application of adverse drug reaction data to drug choice decisions made by pharmacy and therapeutics committees. An Australian perspective.药品不良反应数据在药学与治疗学委员会药物选择决策中的应用。澳大利亚视角。
Drug Saf. 1998 Mar;18(3):153-9. doi: 10.2165/00002018-199818030-00001.
9
Pilot drug and therapeutic committee programme in Sierra Leone: A descriptive mixed method study.塞拉利昂先导药物和治疗委员会方案:一项描述性混合方法研究。
Br J Clin Pharmacol. 2023 Jan;89(1):20-33. doi: 10.1111/bcp.14716. Epub 2021 Feb 10.
10
Drug and therapeutics committees in Danish hospitals: a survey of organization, activities and drug selection procedures.丹麦医院的药物和治疗学委员会:组织、活动和药物选择程序调查。
Basic Clin Pharmacol Toxicol. 2013 Apr;112(4):264-9. doi: 10.1111/bcpt.12028. Epub 2012 Dec 20.

引用本文的文献

1
Drug and therapeutics committee interventions in managing irrational drug use and antimicrobial stewardship in China.中国药物与治疗学委员会在管理不合理用药和抗菌药物管理方面的干预措施。
Front Pharmacol. 2022 Jul 22;13:829408. doi: 10.3389/fphar.2022.829408. eCollection 2022.
2
Drug and therapeutics committees in Jordanian hospitals: a nation-wide survey of organization, activities, and drug selection procedures.约旦医院的药物与治疗学委员会:一项关于组织、活动及药物选择程序的全国性调查。
Pharm Pract (Granada). 2019 Oct-Dec;17(4):1590. doi: 10.18549/PharmPract.2019.4.1590. Epub 2019 Nov 3.
3
Exploring the Impact of the Rational Antibiotic Use System on Hospital Performance: The Direct Effect and the Spillover Effect.
探索合理使用抗生素制度对医院绩效的影响:直接效应和溢出效应。
Int J Environ Res Public Health. 2019 Sep 18;16(18):3463. doi: 10.3390/ijerph16183463.
4
The right drug, but from whose perspective? A framework for analysing the structure and activities of drug and therapeutics committees.正确的药物,但从谁的角度来看?分析药物和治疗学委员会的结构和活动的框架。
Eur J Clin Pharmacol. 2013 May;69 Suppl 1(Suppl 1):79-87. doi: 10.1007/s00228-013-1491-y. Epub 2013 May 3.
5
Selection of medicines in Chilean public hospitals: an exploratory study.智利公立医院药品选择:一项探索性研究。
BMC Health Serv Res. 2013 Jan 7;13:10. doi: 10.1186/1472-6963-13-10.
6
Hospital drug and therapeutics committees in Australia: is there a role for economic evaluation at the institutional level?澳大利亚医院药物和治疗学委员会:在机构层面上进行经济评估是否有作用?
Int J Clin Pharm. 2011 Dec;33(6):895-7. doi: 10.1007/s11096-011-9565-3.
7
Drug selection in French university hospitals: analysis of formularies for nine competitive pharmacological classes.法国大学医院的药物选择:对九种竞争药物类别的处方集进行分析。
Br J Clin Pharmacol. 2011 Nov;72(5):823-31. doi: 10.1111/j.1365-2125.2011.03997.x.
8
Establishing and strengthening a medicine and therapeutics committee in a medical college in Nepal: initial experiences.在尼泊尔一所医学院建立并加强药物与治疗学委员会:初步经验
Pharm World Sci. 2009 Apr;31(2):241-5. doi: 10.1007/s11096-008-9263-y. Epub 2008 Dec 5.
9
Hospital-based adverse drug reaction bulletin : an Indian experience.基于医院的药品不良反应公告:印度的经验
Drug Saf. 2007;30(5):457-9. doi: 10.2165/00002018-200730050-00008.
10
Prioritising drug and therapeutics committee (DTC) decisions: a national survey.药物与治疗学委员会(DTC)决策的优先级排序:一项全国性调查。
Pharm World Sci. 2007 Apr;29(2):90-6. doi: 10.1007/s11096-006-9074-y. Epub 2006 Dec 23.